Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
16 studies found for:    lymphoseek
Show Display Options
Rank Status Study
1 Completed
Has Results
Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes
Conditions: Breast Cancer;   Melanoma
Intervention: Drug: Lymphoseek
2 Completed
Has Results
Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma
Conditions: Breast Cancer;   Melanoma
Intervention: Drug: Lymphoseek
3 Recruiting Sentinel Lymph Node Biopsy Findings in Patients With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Lymphoseek;   Drug: Sulfur Colloid
4 Recruiting Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium
Condition: Endometrial Cancer
Intervention: Drug: Lymphoseek plus Vital Blue Dye
5 Withdrawn A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus
Condition: Anal Cancer
Intervention: Drug: Lymphoseek
6 Active, not recruiting Lymphoseek® as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC)
Conditions: Colon Cancer;   Rectal Cancer
Intervention: Drug: Lymphoseek and VBD Sln dissection
7 Terminated
Has Results
Evaluation of Sentinel Lymph Nodes in Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma (HNSCC)
Intervention: Drug: Lymphoseek
8 Recruiting A Trial of Comparing the Pathology Status of Lymphoseek®-Identified Sentinel Lymph Nodes Relative to the Pathological Pathology Status of Nonsentinel Lymph Nodes in Nodal Staging of Subjects With Known Cancer of the Cervix Who Are Undergoing Lymph Node Dissection
Condition: Uterine Cervical Neoplasms
Intervention: Drug: Tc99m tilmanocept
9 Active, not recruiting A Study Comparing Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Pediatric Patients With Melanoma, Rhabdomyosarcoma, or Other Solid Tumors Who Are Undergoing Lymph Node Mapping
Conditions: Rhabdomyosarcoma;   Melanoma
Interventions: Drug: Tc99m tilmanocept;   Drug: Vital Blue Dye
10 Enrolling by invitation Use of 99mTc Tilmanocept for Imaging Arterial Inflammation
Condition: HIV
Intervention: Other: Arterial Imaging
11 Not yet recruiting An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) Injection in Kaposi Sarcoma (KS)
Conditions: Kaposi Sarcoma;   Hiv
Intervention: Drug: Tc99m-tilmanocept
12 Not yet recruiting Evaluation of Tilmanocept by IV Injection and SC Injection vs PET Imaging in Subjects With Liver Metastases.
Condition: Liver Metastases
Intervention: Drug: Tilmanocept (Technetium Tc 99m tilmanocept Injection)
13 Completed Evaluation of SC Injected Tc 99m Tilmanocept Localization in Active RA Subjects by SPECT and SPECT/CT Imaging
Condition: Rheumatoid Arthritis
Intervention: Drug: tilmanocept
14 Completed
Has Results
Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT
Condition: Kaposi's Sarcoma
Intervention: Drug: Tc 99m tilmanocept
15 Completed Sentinel Lymph Node Mapping Post-Injection Site Pain
Condition: Breast Cancer
Interventions: Drug: Tilmanocept;   Drug: Sulfur Colloid
16 Recruiting Targeted Silica Nanoparticles for Image-Guided Intraoperative Sentinel Lymph Node Mapping in Head and Neck Melanoma, Breast and Gynecologic Malignancies
Conditions: Head and Neck Melanoma;   Gynecologic Malignancies;   Breast Cancer
Intervention: Drug: fluorescent cRGDY-PEG-Cy5.5-C dots

Study has passed its completion date and status has not been verified in more than two years.